StockData
Verrica Pharmaceuticals Inc. logo

Verrica Pharmaceuticals Inc. (VRCA) stock

VRCANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$3.14−0.06 (-1.88%)

Close on Nov 17, 2026Market cap $53.94MP/E –Yield –

Verrica Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Verrica Pharmaceuticals's market cap was $67.17M on Nov 11, 2026, against $86.36M a year earlier. Over the last 5 years it ranged from $29.53M to $360.99M, with a median of $99.77M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$67.17M-14.8%
2025Dec 31, 2025$78.86M+147.1%
2024Dec 31, 2024$31.92M-89.6%
2023Dec 29, 2023$307.91M+172.5%
2022Dec 30, 2022$113.01M-55.2%
2021Dec 31, 2021$252.07M-15.3%
2020Dec 31, 2020$297.71M-27.2%
2019Dec 31, 2019$409.08M+95.3%
2018Dec 31, 2018$209.43M–

More Verrica Pharmaceuticals figures

See a number that looks wrong?